Breakthrough in the combat of multi-resistant bacteria
The privately financed research company founded in 2009 is a leader in technology in the field of antimicrobial proteins and has researched artificial designer proteins with an international team of scientists. The result represents a revolutionary breakthrough in the combat of multi-resistant bacteria. With this new technology platform, targeted development of medicines and active substances can be developed for pathogenic gram-negative and gram-positive bacteria, as well as antibiotic-resistant and persistent bacteria. This innovative technology works very rapidly and specifically, is completely biodegradable and possesses enhanced stability to resistance.
For further information see: